- Research works
- 3 ▼ 88% vs 2013–17
- Citations
- 84 29.4 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 70% world 28%
Not ranked overall: RiboMed Biotechnologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does RiboMed Biotechnologies (United States) publish most on?
By volume in 2022–2025: Microbial Metabolic Engineering and Bioproduction, Tuberculosis Research and Epidemiology, Gut microbiota and health and Autophagy in Disease and Therapy.
- 1 Microbial Metabolic Engineering and Bioproduction Molecular Biology 0 works
- 2 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
- 3 Gut microbiota and health Molecular Biology 0 works
- 4 Autophagy in Disease and Therapy Epidemiology 0 works
- 5 Cannabis and Cannabinoid Research Pharmacology 0 works
- 6 Probiotics and Fermented Foods Food Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has RiboMed Biotechnologies (United States)'s research output changed?
Output in 2018–2022 was 88% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Carlsbad
- Ionis Pharmaceuticals (United States)
- Jones Institute
- Gemological Institute of America
- Viasat (United States)
- Flometrics (United States)
- Neuroscience Education Institute
- Lineage Cell Therapeutics (United States)
- Structural Analytics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.